论文部分内容阅读
目的研究头孢哌酮钠舒巴坦钠治疗肝炎后肝硬化并发自发性细菌性腹膜炎(SBP)的临床效果。方法选取我院2011年1月~2013年12月肝炎后肝硬化并发SBP患者68例,随机分为观察组和对照组各34例。观察组给予头孢哌酮钠舒巴坦钠治疗,对照组给予左氧氟沙星治疗,比较两组患者的临床疗效。结果观察组总有效率明显高于对照组,两组比较差异具有统计学意义(P<0.05)。结论头孢哌酮钠舒巴坦钠治疗肝炎后肝硬化并发SBP疗效显著,值得临床推广应用。
Objective To study the clinical efficacy of cefoperazone sodium and sulbactam sodium in the treatment of post-hepatitis cirrhosis complicated with spontaneous bacterial peritonitis (SBP). Methods Sixty-eight patients with hepatitis B cirrhosis complicated with SBP from January 2011 to December 2013 in our hospital were randomly divided into observation group (34 cases) and control group (34 cases). The observation group was given cefoperazone sodium and sulbactam sodium, the control group was treated with levofloxacin, the clinical efficacy of the two groups were compared. Results The total effective rate of the observation group was significantly higher than that of the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion Cefoperazone sodium and sulbactam sodium in the treatment of posthepatitic cirrhosis complicated with significant effect of SBP, worthy of clinical application.